MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-22-0003367
Indoraggu Pharmaceuticals Private Limited
Indoraggu Pharmaceuticals Private Limited - trading in Mysore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11 Lakh
▼ 45% YoY
Net loss · FY 2024
₹3,813
Net margin -0.3%
EBITDA · FY 2024
-₹55
EBITDA margin 0%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Indoraggu Pharmaceuticals Private Limited
Data last updated:
Indoraggu Pharmaceuticals Private Limited is a private limited company based in Mysore, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 28 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2019PTC128366. Its GSTIN is 29AAFCI4209R1ZZ (Karnataka).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Mahadeva Doddachari and Basavaraju Kavudavadi Prabhuswamy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.2852/1 Ch – 57/1 Shop No.4 Ground Floor 2nd Main 4th Cross Jayanagar, Mysore, Karnataka, India – 570014.
As per the financials filed for FY 2024, the company reported a revenue of ₹11 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹3,813 (net margin -0.3%) and EBITDA of -₹55 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
Indoraggu Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0003367).
Company details
CIN U51909KA2019PTC128366
Registration Number 128366
Incorporation Date 28 September 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-22-0003367
Recognitions & Rankings of Indoraggu Pharmaceuticals
Contact details
Indoraggu Pharmaceuticals Private Limited's registered office is in Mysore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo.2852/1 Ch – 57/1 Shop No.4 Ground Floor 2nd Main 4th Cross Jayanagar, Mysore, Karnataka, India – 570014
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Indoraggu Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Indoraggu Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Indoraggu Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Indoraggu Pharmaceuticals Private Limited, buy the company report.
Financials of Indoraggu Pharmaceuticals Private Limited
FY 2025 filings availableIndoraggu Pharmaceuticals Private Limited reported revenue of ₹11 Lakh (down 45% YoY) for FY 2024.
Revenue · FY 2024
₹11 Lakh ▼ 45%
Net loss · FY 2024
₹3,813 margin -0.3%
EBITDA · FY 2024
-₹55 margin 0%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 89%
Revenue fell 45% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹55 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,813 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indoraggu Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indoraggu Pharmaceuticals Private Limited
Indoraggu Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahadeva Doddachari | Director | 28 Sep 2019 | 7 Years 1 Months | Current |
| Basavaraju Kavudavadi Prabhuswamy | Director | 28 Sep 2019 | 7 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Indoraggu Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indoraggu Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indoraggu Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCI4209R1ZZ | Karnataka | Active | 18 Nov 2019 |
To see the full GST registrations and return filing status of Indoraggu Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indoraggu Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Sulugodusomavara Devarajegowda Ramesh ceased to be Additional Director on 16 Oct 2020.
AGM
Indoraggu Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Indoraggu Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Sulugodusomavara Devarajegowda Ramesh ceased to be Additional Director.
Ceased
Vijayakumar Kabbur Shivappa ceased to be Director.
Appointed
Basavaraju Kavudavadi Prabhuswamy was appointed as Director.
Appointed
Mahadeva Doddachari was appointed as Director.
Incorporation
28 Sep 2019
Indoraggu Pharmaceuticals Private Limited was registered on 28 Sep 2019 with Roc Bangalore & aged 7 years 1 month as per MCA records.
Frequently asked questions
Indoraggu Pharmaceuticals is an active private limited company based in Mysore, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 28 September 2019 (7+ years old) and is registered under CIN U51909KA2019PTC128366.
Indoraggu Pharmaceuticals has 2 current directors:
- Mahadeva Doddachari - Director
- Basavaraju Kavudavadi Prabhuswamy - Director
The latest financial statements of Indoraggu Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Indoraggu Pharmaceuticals is 29AAFCI4209R1ZZ, registered in Karnataka.
The CIN (Corporate Identification Number) of Indoraggu Pharmaceuticals is U51909KA2019PTC128366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indoraggu Pharmaceuticals was incorporated on 28 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Sulugodusomavara Devarajegowda Ramesh ceased to be Additional Director on 16 Oct 2020. Vijayakumar Kabbur Shivappa ceased to be Director on 16 Oct 2020. Basavaraju Kavudavadi Prabhuswamy was appointed as Director on 28 Sep 2019. Indoraggu Pharmaceuticals has 4 board changes on record in total.
Yes, Indoraggu Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0003367).
The registered office of Indoraggu Pharmaceuticals is at No.28521 Ch – 571 Shop No.4 Ground Floor 2nd Main 4th Cross Jayanagar, Mysore, Karnataka, India – 570014.
Indoraggu Pharmaceuticals operates in the trading industry, in the specialty segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages